Davies said several agents in phase 2 and phase 3 trials have induced large reductions in both HbA1c and body weight for people with type 2 diabetes
There are rare thyroid tumors
and renal outcomes included nephrolithiasis, acute kidney injury, ureterolithiasis, chronic kidney disease, calculus urinary, hydronephrosis, renal colic, and renal failure
There are many reasons why someone might want to try GLP-1 microdosing
AndreadisPKaragiannisTMalandrisKAvgerinosILiakosAManolopoulosAet al
3 min read The popularity of GLP-1s has skyrocketed in recent years, and a November 26 proposal from President Joe Bidens administration to allow Medicare and Medicaid to cover the medications could make them even more prominent